# FDA Inspection 1283454 - SpecGx LLC - October 22, 2025

Source: https://www.keypedia.com/records/fda_inspections/specgx-llc/cbc1b2fb-753f-4dd6-aa20-30ef2fbc7c06
Source feed: FDA_Inspections

> FDA Inspection 1283454 for SpecGx LLC on October 22, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1283454
- Company Name: SpecGx LLC
- Inspection Date: 2025-10-22
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1283454 - 2025-10-22](https://www.keypedia.com/records/fda_inspections/specgx-llc/24ece6fd-a035-4331-89ab-8ddb59db42f9)
- [FDA Inspection 1283454 - 2025-10-22](https://www.keypedia.com/records/fda_inspections/specgx-llc/4ef58d63-e23f-4c06-9834-380b593fbb90)
- [FDA Inspection 1283454 - 2025-10-22](https://www.keypedia.com/records/fda_inspections/specgx-llc/4554a61d-9334-4f7c-8b16-11f2c2cbfe6a)
- [FDA Inspection 1163660 - 2022-02-11](https://www.keypedia.com/records/fda_inspections/specgx-llc/42e52827-265a-4039-8bff-a00d227c7ee8)
- [FDA Inspection 1103208 - 2019-09-12](https://www.keypedia.com/records/fda_inspections/specgx-llc/75d21b61-9c72-4784-bf5f-16c5e92499a8)

Company: https://www.keypedia.com/companies/specgx-llc/a659fe71-9183-4c7c-96ca-9214c6a9c177

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c